Hillevi Bauer

736 total citations
21 papers, 560 citations indexed

About

Hillevi Bauer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Hillevi Bauer has authored 21 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Hillevi Bauer's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Cell Adhesion Molecules Research (3 papers) and Prostate Cancer Treatment and Research (3 papers). Hillevi Bauer is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Cell Adhesion Molecules Research (3 papers) and Prostate Cancer Treatment and Research (3 papers). Hillevi Bauer collaborates with scholars based in United States, Germany and India. Hillevi Bauer's co-authors include Hamidreza Ghandehari, Khaled Greish, Abhijit Ray, Nate Larson, Pavla Kopečková, Jindřich Kopeček, Huaizhong Pan, Jarrad M. Scarlett, Jeffrey S. Mandel and Clyde E. Blackard and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Hillevi Bauer

19 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hillevi Bauer United States 11 200 171 119 106 101 21 560
Margit M. Janát‐Amsbury United States 16 365 1.8× 202 1.2× 184 1.5× 138 1.3× 71 0.7× 34 856
Melissa Griffin Canada 10 147 0.7× 245 1.4× 140 1.2× 150 1.4× 33 0.3× 13 530
Qinglian Wen China 18 284 1.4× 172 1.0× 164 1.4× 195 1.8× 100 1.0× 48 756
P. Vasey United Kingdom 4 274 1.4× 359 2.1× 126 1.1× 200 1.9× 40 0.4× 7 649
Henrike Caysa Germany 13 211 1.1× 225 1.3× 115 1.0× 237 2.2× 35 0.3× 15 662
Seock Ah Im South Korea 9 320 1.6× 330 1.9× 288 2.4× 215 2.0× 80 0.8× 23 806
Ela Markovsky Israel 11 268 1.3× 298 1.7× 115 1.0× 179 1.7× 72 0.7× 15 696
Tianzhu Yu China 12 287 1.4× 61 0.4× 100 0.8× 98 0.9× 97 1.0× 24 571
Kun‐Lung Chuang Taiwan 8 148 0.7× 127 0.7× 70 0.6× 101 1.0× 156 1.5× 13 429
Suo-Qin Tang China 12 295 1.5× 241 1.4× 91 0.8× 208 2.0× 34 0.3× 41 570

Countries citing papers authored by Hillevi Bauer

Since Specialization
Citations

This map shows the geographic impact of Hillevi Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hillevi Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hillevi Bauer more than expected).

Fields of papers citing papers by Hillevi Bauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hillevi Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hillevi Bauer. The network helps show where Hillevi Bauer may publish in the future.

Co-authorship network of co-authors of Hillevi Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Hillevi Bauer. A scholar is included among the top collaborators of Hillevi Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hillevi Bauer. Hillevi Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bauer, Hillevi, Jyothi U. Menon, Sudhir Unni, et al.. (2022). Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study. Oncotarget. 13(1). 257–270. 3 indexed citations
3.
Stenehjem, David D., Sudhir Unni, Hillevi Bauer, et al.. (2021). BRCA testing and outcomes in women with breast cancer. Breast Cancer Research and Treatment. 186(3). 839–850. 8 indexed citations
4.
Stenehjem, David D., Surachat Ngorsuraches, Junjie Ma, et al.. (2019). Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center. Melanoma Research. 29(6). 626–634. 18 indexed citations
5.
Stenehjem, David D., Hillevi Bauer, Krystal Brown, et al.. (2018). Impact of a genetic counseling requirement prior to genetic testing. BMC Health Services Research. 18(1). 165–165. 28 indexed citations
6.
Bauer, Hillevi, Jyothi U. Menon, Eli Iacob, et al.. (2018). Impact of glioblastoma (GBM)-related cognitive dysfunction (CD) on caregiver burden: Preliminary results from multi-site study in the U.S.. Journal of Clinical Oncology. 36(34_suppl). 16–16. 1 indexed citations
7.
Bauer, Hillevi, Junjie Ma, Prianka Singh, et al.. (2017). HOUT-19. DEVELOPMENT OF A NOVEL BURDEN SURVEY FOR CAREGIVERS OF GLIOBLASTOMA MULTIFORME (GBM) PATIENTS. Neuro-Oncology. 19(suppl_6). vi110–vi110.
8.
Stenehjem, David D., et al.. (2015). Understanding The Impact Of Patient And Physician Preferences In Personalized Treatment For Melanoma Using A Discrete Choice Experiment. Value in Health. 18(7). A469–A470. 2 indexed citations
9.
Stenehjem, David D., Minkyoung Yoo, Sudhir Unni, et al.. (2014). Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer. Breast Cancer Targets and Therapy. 6. 169–169. 17 indexed citations
10.
Stenehjem, David D., Frederick S. Albright, Karina Raimundo, et al.. (2014). Response Monitoring, Tolerability, and Effectiveness of Imatinib Treatment for Chronic Myeloid Leukemia in a Retrospective Research Database. Journal of the National Comprehensive Cancer Network. 12(8). 1113–1121. 6 indexed citations
11.
Ray, Abhijit, Nate Larson, Daniel B. Pike, et al.. (2011). Comparison of Active and Passive Targeting of Docetaxel for Prostate Cancer Therapy by HPMA Copolymer–RGDfK Conjugates. Molecular Pharmaceutics. 8(4). 1090–1099. 48 indexed citations
12.
Larson, Nate, Khaled Greish, Hillevi Bauer, Hiroshi Maeda, & Hamidreza Ghandehari. (2011). Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin. International Journal of Pharmaceutics. 420(1). 111–117. 38 indexed citations
13.
Greish, Khaled, Abhijit Ray, Hillevi Bauer, et al.. (2011). Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy. Journal of Controlled Release. 151(3). 263–270. 37 indexed citations
14.
Greish, Khaled, Giridhar Thiagarajan, Robert Price, et al.. (2011). Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology. 6(7). 713–723. 128 indexed citations
15.
Liu, Jihua, et al.. (2010). Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics. Journal of Controlled Release. 143(1). 71–79. 54 indexed citations
16.
Liu, Jihua, Pavla Kopečková, Patrick Bühler, et al.. (2009). Biorecognition and Subcellular Trafficking of HPMA Copolymer−Anti-PSMA Antibody Conjugates by Prostate Cancer Cells. Molecular Pharmaceutics. 6(3). 959–970. 64 indexed citations
17.
Siess, M., R Bartkowski, P. Hermanek, et al.. (2001). [Effects of the DRG-based payment system. What action requirement exists for the surgeon?].. PubMed. 72(2). suppl 30–5. 1 indexed citations
18.
Bauer, Joseph A., et al.. (1995). [Premorbid psychological processes in patients with Alzheimer's disease and in patients with vascular dementia].. PubMed. 28(3). 179–89. 16 indexed citations
19.
Mandel, Jeffrey S., et al.. (1977). Epidemiologic study of prostatic cancer: preliminary report.. PubMed. 61(2). 181–6. 88 indexed citations
20.
Bauer, Hillevi, et al.. (1976). [Non-resecting surgery for gastroduodenal ulcer. I. Pathophysiological principles (author's transl)].. PubMed. 118(24). 767–76. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margit M. Janát‐Amsbury Breakdown of academic impact, for papers by Melissa Griffin Breakdown of academic impact, for papers by Qinglian Wen Breakdown of academic impact, for papers by P. Vasey Breakdown of academic impact, for papers by Henrike Caysa Breakdown of academic impact, for papers by Seock Ah Im Breakdown of academic impact, for papers by Ela Markovsky Breakdown of academic impact, for papers by Tianzhu Yu Breakdown of academic impact, for papers by Kun‐Lung Chuang Breakdown of academic impact, for papers by Suo-Qin Tang
Rankless by CCL
2026